MedPath

Effect of the Homoeopathic Medicine Solidago virgaurea in the treatment of albumin in urine of Diabetic patients

Completed
Conditions
Type 2 diabetes mellitus with kidney complications,
Registration Number
CTRI/2023/02/049934
Lead Sponsor
Vinayaka Missions Homoeopathic Medical College and Hospital
Brief Summary

Diabetes mellitus is the main cause of end-stage renal disease. Most cases of diabetes mellitus develop into diabetic nephropathy and albuminuria is seen at the time of diagnosis. Microalbuminuria is a clinical sign that indicates vascular damage in the glomerulus which leads to diabetic nephropathy. Microalbuminuria is estimated by the urinary albumin/creatinine ratio, a significant side effect of type II diabetes mellitus is diabetic nephropathy which is characterized by an increased urine albumin excretion rate which eventually results in end-stage renal disease. Hence diabetes mellitus should be monitored regularly for microalbuminuria.

Homeopathic medicines like Helonias, lycopodium, Abroma augusta, Cephalandra indica, Gymnema sylvestre, Syzygium jambolanum, insilin, glycerinum, acid phosphoricum, carbolicum acidum, terebinthinae etc.,

are some of the homeopathic remedies indicated for diabetes. Solidago is effective in the treatment of diabetic nephropathy as it is indicated for albumin, blood, slime in urine, pain in the region of the kidney and kidneys are sensitive to pressure. These are the details that intended me to assess the microalbuminuria levels in diabetic nephropathy patients treated with Solidago virgaurea 6CH by performing a clinical case series study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Diabetic Nephropathy patients with ACR value >2.5mg/mmol creatinine in males ACR value >3.5mg/mmol creatinine in females.

Exclusion Criteria
  • Patients suffering from other renal diseases 2.
  • Gestational diabetic patients 3.
  • Diabetes Mellitus patients with Multi-System Involvement.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of ACR value60 days
Reduction of urine albumin excretion levels, control of blood glucose levels, Improvement of e-GFR60 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vinayaka Missions Homoeopathic Medical College and Hospital

🇮🇳

Salem, TAMIL NADU, India

Vinayaka Missions Homoeopathic Medical College and Hospital
🇮🇳Salem, TAMIL NADU, India
Dr H Venkatesan
Principal investigator
9865134561
venkathompath@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.